Temozolomide in combination with BCNU before and after radiotherapy in patients with inoperable newly diagnosed glioblastoma multiforme

Annals of Oncology

Volumn 16, Issue 7, 2005, Pages 1177-1184

  Barrie M ^a   Couprie, C ^a   Dufour, H ^a   Figarella Branger, D ^a   Muracciole, X ^a   Hoang Xuan, K ^b   Braguer, D ^a   Martin, P M ^c   Peragut, J C ^a   Grisoli, F ^a   Chinot, Olivier ^a,c  

^a TIMONE HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

3 bis(2 chloroethyl) 1 nitrosourea (BCNU); Chemotherapy neo adjuvant strategy; Glioblastoma; Inoperable brain tumor; Temozolomide

Indexed keywords

CARMUSTINE; TEMOZOLOMIDE; ANTINEOPLASTIC AGENT; DACARBAZINE; DRUG DERIVATIVE;

ADULT; AGE; AGED; ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW SUPPRESSION; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FATALITY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; GLIOBLASTOMA; HUMAN; INOPERABLE CANCER; LUNG DISEASE; MALE; NAUSEA; NEUTROPENIA; PRIMARY HEALTH CARE; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TUMOR LOCALIZATION; VOMITING; BRAIN TUMOR; DISEASE FREE SURVIVAL; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; SURVIVAL;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARMUSTINE; COMBINED MODALITY THERAPY; DACARBAZINE; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 25444516747     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdi225     Document Type: Article

References (32)

1. Chinot OL. Should radiotherapy be standard therapy for brain tumors in the elderly? Cons Semin Oncol 2003; 30 (Suppl): 68-71.
2. Green SB, Byar DP, Walker MD et al. Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep 1983; 67: 121-132.
3. Chang CH, Horton J, Schoenfeld D et al. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer 1983; 52: 997-1007.
4. Shapiro WR, Green SB, Burger PC et al. Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group trial 8001. J Neurosurg 1989; 71: 1-9.
5. Medical Research Council Brain Tumor Working Parry. Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: A Medical Research Council trial. J Clin Oncol 2001; 19: 509-518.
6. Stewart LA. Chemotherapy in adult high-grade glioma: A systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 2002; 359: 1011-1018.
7. Stupp R, Mason WP, Van Den Bent MJ et al. Concomitant and adjuvant temozolomide (TMZ) and radiotherapy (RT) for newly diagnosed glioblastoma multiforme (GBM). Conclusive results of a randomized phase III trial by the EORTC Brain & RT Groups and NCIC Clinical Trials Group. Proc Am Soc Clin Oncol 2004; 23: 1 (Abstr 2).
8. Recht L, Fram RJ, Strauss G et al. Preirradiation chemotherapy of supratentorial malignant primary brain tumors with intracarotid cisplatinum (CDDP) and i.v. BCNU. A phase II trial. Am J Clin Oncol 1990; 13: 125-131.
9. Kirby S, Macdonald D, Fisher B et al. Pre-radiation chemotherapy for malignant glioma in adults. Can J Neurol Sci 1996; 23: 123-127.
10. 6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma. J Clin Oncol 1998; 16: 3851-3857.
11. Jeremic B, Shibamoto Y, Grujicic D et al. Pre-irradiation carboplatin and etoposide and accelerated hyperfractionated radiation therapy in patients with high-grade astrocytomas: A phase II study. Radiother Oncol 1999; 51: 27-33.
12. Frenay M, Lebrun C, Lonjon M et al. Up-front chemotherapy with fotemustine (F)/cisplatin (CDDP)/etoposide (VP16) regimen in the treatment of 33 non-removable glioblastomas. Eur J Cancer 2000; 36: 1026-1031.
13. Gilbert M, O'Neill A, Grossman S et al. A phase II study of preradiation chemotherapy followed by external beam radiotherapy for the treatment of patients with newly diagnosed glioblastoma multiforme: An Eastern Cooperative Oncology Group study (E2393). Neuro-oncol 2000; 47: 145-152.
14. Gilbert MR, Friedman HS, Kuttesch IF et al. A phase II study of temozolomide in patients with newly diagnosed supratentorial malignant glioma before radiation therapy. Neuro-oncol 2002; 4: 261-267.
15. Stupp R, Dietrich P-Y, Kraljevic SO et al. Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol 2002; 20: 1375-1382.
16. Plowman J, Waud WR, Koutsoukos AD et al. Preclinical antitumor activity of temozolomide in mice: Efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res 1994; 54: 3793-3799.
17. Lee SM, Thatcher N, Crowther D, Margison GP. Inactivation of O6-alkylguanine-DNA alkyltransferase in human peripheral blood mononuclear cells by temozolomide. Br J Cancer 1994; 69: 452-456.
18. Pegg AE. Mammalian O6-alkylguanine-DNA alkyltransferase: Regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res 1990; 50: 6119-6129.
19. Gerson SL. Regeneration of O6-alkylguanine-DNA alkyltransferase in human lymphocytes after nitrosourea exposure. Cancer Res 1988; 48: 5368-5373.
20. Mitchell RB, Dolan ME. Effect of temozolomide and dacarbazine on O6-alkylguanine-DNA alkyltransferase activity and sensitivity of human tumor cells and xenografts to 1,3-bis(2-chloroethyl)-1-nitro-sourea. Cancer Chemother Pharmacol 1993; 32: 59-63.
21. Schold SC Jr, Kuhn JG, Chang SM et al. A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide: A North American Brain Tumor Consortium study [published erratum appears in Neurooncol 2001; 3 123]. J Neuro-ncol 2000; 2: 34-39.
22. Prados MD, Yung WK, Fine HA et al. Phase 2 study of BCNU and temozolomide for recurrent glioblastoma multiforme: North American Brain Tumor Consortium study. Neuro-oncol 2004; 6: 33-37.
23. Chang SM, Prados MD, Yung WKA et al. Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: A North American Brain Tumor Consortium Trial. Cancer 2004; 100: 1712-1716.
24. Hammond LA, Eckardt JR, Kuhn JG et al. A randomized phase I and pharmacological trial of sequences of 1,3-bis(2-chloroethyl)-1-nitro-sourea and temozolomide in patients with advanced solid neoplasms. Clin Cancer Res 2004; 10: 1645-1656.
25. Macdonald DR, Cascino TL, Schold SC Jr, Cairncross JG. Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 1990; 8: 1277-1280.
26. Chinot O, Barrie M, Couprie C et al. Preradiation combination of temozolomide (TMZ) and BCNU as primary treatment before radiotherapy (RT) in inoperable newly diagnosed glioblastoma multiforme (GBM) [poster]. Presented at the 39th Annual Meeting of the American Society of Clinical Oncology 31 May to 3 June 2003, Chicago, IL, USA. Proc Am Soc Clin Oncol: 108 (Abstr 431).
27. Curran WJ Jr, Scott CB, Horton J et al. Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 1993; 85: 704-710.
28. Grossman SA, Wharam M, Sheidler V et al. Phase II study of continuous infusion carmustine and cisplatin followed by cranial irradiation in adults with newly diagnosed high-grade astrocytoma. J Clin Oncol 1997; 15: 2596-2603.
29. Dazzi C, Cariello A, Giannini M et al. A sequential chemo-radiotherapeutic treatment for patients with malignant gliomas: A phase II pilot study. Anticancer Res 2000; 20: 515-518.
30. Coffey RJ, Lunsford LD, Taylor FH. Survival after stereotactic biopsy of malignant gliomas. Neurosurgery 1988; 22: 465-473.
31. Simon JM, Noel G, Chiras J et al. Radiotherapy and chemottherapy with or without carbogen and nicotinamide in inoperable biopsy-proven glioblastoma multiforme. Radiother Oncol 2003; 67: 45-51.
32. Friedman HS, Dolan ME, Pegg AE et al. Activity of temozolomide in the treatment of central nervous system tumor xenografts. Cancer Res 1995; 55: 2853-2857.